Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Priveterra Acquisition Corp. PMGM | Citadel Advisors LLC | 1,658 0.000% | -1,379,464 (-99.88%) | Filing History |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Ibere Pharmaceuticals IBER | Citadel Advisors LLC | 4,057 0.000% | -775,377 (-99.48%) | Filing History |
| 2023-02-14 08:14 am Purchase | 2022-12-31 | 13G | Akili, Inc. AKLI | Citadel Advisors LLC | 19,515 0.000% | 19,515 (New Position) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Independence Holdings Corp. ACQR | Citadel Advisors LLC | 3,756,877 7.600% | -400,258 (-9.63%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 23,299 7.400% | 164 (+0.71%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Bilander Acquisition Corp. TWCB | Citadel Advisors LLC | 1,212,037 7.200% | -73,522 (-5.72%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Apollo Strategic Growth Capital II APGB | Citadel Advisors LLC | 4,078,643 5.900% | -51,113 (-1.24%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Calithera Biosciences, Inc. CALA | Citadel Advisors LLC | 249,336 5.100% | 249,336 (New Position) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,981,324 5.700% | 116,524 (+4.07%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Forbion European Acquisition Corp. FRBN | Citadel Advisors LLC | 1,075,058 8.500% | 1,075,058 (New Position) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | G Squared Ascend II Inc. GSQB | Citadel Advisors LLC | 1,220,439 8.500% | 85 (+0.01%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 179,595 5.900% | 2,244 (+1.27%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Khosla Ventures Acquisition Co. KVSA | Citadel Advisors LLC | 2,705,290 7.600% | 370,682 (+15.88%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Khosla Ventures Acquisition Co. III KVSC | Citadel Advisors LLC | 3,404,141 5.900% | 580,377 (+20.55%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO | Citadel Advisors LLC | 2,241,549 6.500% | -405,087 (-15.31%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | MSD Acquisition Corp. MSDA | Citadel Advisors LLC | 3,428,296 6.000% | -60,921 (-1.75%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Motive Capital Corp II MTVC | Citadel Advisors LLC | 2,500,443 7.300% | 262 (+0.01%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Oncorus, Inc. ONCR | Citadel Advisors LLC | 2,017,854 7.800% | 116,545 (+6.13%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Panacea Acquisition Corp. II PANA | Citadel Advisors LLC | 1,501,251 8.400% | 273,545 (+22.28%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Jackson Acquisition Company RJAC | Citadel Advisors LLC | 1,256,919 5.700% | 1,256,919 (New Position) | Filing History |